RT Journal Article
SR Electronic
T1 Baseline characteristics among 101,407 people with myocardial infarction over nine-year time period: a population-based study using primary care data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.17.24310434
DO 10.1101/2024.07.17.24310434
A1 Arsene, Corneliu T
YR 2024
UL http://medrxiv.org/content/early/2024/07/17/2024.07.17.24310434.abstract
AB CardioVascular (CV) Disease (CVD) accounts for 25% of all UK deaths [1-4]. Before developing and applying new or existing CV risk prediction tools [5-22] for prediction of incident CVD events, it is important to have a description of the baseline characteristics of the patients who experienced a myocardial Infarction (MI) event. This paper presents the baseline characteristics of a cohort of patients who experienced a first MI between 1st of January 2006 and 31st of December 2014 in England, UK, age equal or greater than 35 yearsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe author would like to thank to the Heart Research UK Translation Research Project Grants for supporting this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the CPRD Independent Scientific Advisory Committee (protocol number 20-177). Generic ethical approval for observational research using CPRD with approval from ISAC has been granted by a Health Research Authority (HRA) Research Ethics Committee (East Midlands Derby, REC reference number 05/MRE04/87).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData is not available.